BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2015 7:39:00 PM | Browse: 320 | Download: 435
Publication Name World Journal of Pharmacology
Manuscript ID 12462
Country/Territory United States
Received
2014-07-10 08:36
Peer-Review Started
2014-07-10 11:01
To Make the First Decision
2014-09-16 11:09
Return for Revision
2014-09-23 17:30
Revised
2014-10-22 14:27
Second Decision
2014-12-11 17:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-17 16:23
Articles in Press
2014-12-17 16:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-02-28 11:44
Publish the Manuscript Online
2015-03-12 19:39
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology and Nephrology
Manuscript Type Review
Article Title Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome
Manuscript Source Invited Manuscript
All Author List Asfandyar Khan and Adam B Murphy
Funding Agency and Grant Number
Corresponding author Asfandyar Khan, MD, Department of Urology, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., Tarry 16-729, Chicago, IL 60611, United States. a-khan@northwestern.edu
Key Words Chronic prostatitis; Antibiotics; Myofascial trigger point; Pelvic biofeedback; Chronic pelvic pain syndrome; Phytotherapy; Nanobacteria; Dysfunctional voiding; Acupuncture
Core Tip Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is difficult-to-treat because of the multitude of potential etiologies that are not easily observed and delayed diagnosis. Pharmacological monotherapy with antibiotics, alpha-blockers and anti-inflammatories provide significant symptomatic improvement in a limited number of patients. Multidrug therapies are recommended for monotherapy refractory patients. Complementary and interventional therapies such as acupuncture, myofascial trigger point release and pelvic floor biofeedback can provide additional symptomatic relief. Current recommendations involve a treatment algorithm based on UPOINT phenotypic presentation for CP/CPPS patients. Keeping in mind the high prevalence of CP/CPPS, development of novel therapies and an effective vaccine for prevention of CP/CPPS is crucial.
Publish Date 2015-03-12 19:39
Citation Khan A, Murphy AB. Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome. World J Pharmacol 2015; 4(1): 1-16
Url http://www.wjgnet.com/2220-3192/full/v4/i1/1.htm
DOI http://dx.doi.org/10.5497/wjp.v4.i1.1
Manuscript File 12462-Review.doc
Answering Reviewers 12462-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 12462-Conflict-of-interest statement.pdf
Copyright License Agreement 12462-Copyright assignment.pdf
Peer-review Report 12462-Peer review(s).pdf
Scientific Misconduct Check 12462-CrossCheck.jpg
Scientific Editor Work List 12462-Scientific editor work list.pdf